The Parkinson's drug Comtam for obesity and diabetes

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Obesity; diabetes

In silico and mouse studies identified Comtan entacapone as an FTO inhibitor that could help treat obesity and

Read the full 220 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE